Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Chiral Catalyst. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN111848322B details a novel chiral phosphoric acid catalyzed resolution for axially chiral oxindole styrenes, offering high enantioselectivity and mild conditions for scalable pharmaceutical intermediate production.
Novel oxindole-derived styrene phosphine catalysts enabling high-yield asymmetric cyclizations with mild conditions for fine chemical manufacturing.
Novel axial chiral phosphine catalyst synthesis via chiral phosphoric acid. High ee, mild conditions. Ideal for asymmetric hydrosilylation and coupling. Reliable supplier for pharma intermediates.
Patent CN113195460A details enantioselective iridium-catalyzed hydrogenation of oximes. This breakthrough offers cost reduction in agrochemical intermediate manufacturing and reliable supply chain solutions.
Patent CN101143862B details novel chiral ionic thiourea catalysts offering high enantioselectivity and recyclability for pharmaceutical intermediate manufacturing.
Patent CN106478719B details a novel camphor-based chiral catalyst. Offers high selectivity and metal-free advantages for pharmaceutical intermediates manufacturing cost reduction.
Novel biaryl-based ligand enables high-yield palladium-catalyzed asymmetric allylic substitution with exceptional enantioselectivity and simplified synthesis.
Patent CN111777637B details novel indole-derived styrene phosphine catalysts enabling high-yield asymmetric cyclizations with mild conditions.
Novel organocatalytic method for high-purity axial chiral indole-naphthalenes. Efficient scale-up and cost-effective production for asymmetric catalysis applications.
Novel chiral phosphoric acid catalyzed resolution method for high-purity axially chiral oxindole-substituted styrenes, offering scalable synthesis for pharmaceutical intermediates.
Novel 5,5'-linked biphenyl ligands offering high stereoselectivity. Optimized synthesis for cost-effective pharmaceutical intermediate manufacturing and scalable production.
Patent CN100389877C details a novel PEG-supported ruthenium catalyst enabling ambient pressure asymmetric hydrogenation, offering significant cost reduction and supply chain reliability for API manufacturing.
Novel synthesis method offers high enantioselectivity and significant cost reduction for chiral catalyst manufacturing supply chains globally ensuring reliable pharmaceutical intermediates
Patent CN113735756A details a mild Rh-catalyzed method for chiral 3,3-disubstituted isoindolinones, offering high enantioselectivity and cost-effective manufacturing solutions.
Patent CN118878543A reveals a novel synthesis for axial chiral compounds with high ee. Discover cost-effective manufacturing and supply chain advantages for pharmaceutical intermediates.
Patent CN110452150B discloses a novel organocatalytic route for high-purity axial chiral indole-naphthalenes. This method offers significant cost reduction in chiral catalyst manufacturing and scalable production capabilities.
Patent CN114524701B reveals a novel chiral phosphoric acid catalyzed synthesis of N-N axis chiral pyrroles with high enantioselectivity and cytotoxic activity.
Novel organocatalytic route for high-purity axial chiral indole-naphthalenes. Cost-effective, scalable process for chiral catalyst precursors and pharmaceutical intermediates.
Patent CN114920775B reveals high-selectivity catalyst synthesis. Offers supply chain stability and cost efficiency for pharmaceutical intermediate manufacturing processes.
Novel chiral phosphoric acid catalyzed synthesis of N-N axis pyrroles. High yield, mild conditions, scalable for pharma intermediates.